Migraine trials in Finland

1 trial · From EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind trial (NorMig)

  Where

  Helsinki

  Age

  18 years and over

  People

  550 worldwide

  Run by

  Oslo University Hospital HF

  See details and how to join2024-517981-40-00 · EU 2024-517981-40-00